Dysregulated miR-342 expression induces apoptosis in breast cancer

被引:0
|
作者
Lowery, Aoife
Miller, Nicola
Devaney, Amanda
Dwyer, Roisin
Lemetre, Christophe
Ball, Graham
Kerin, Michael
机构
[1] Natl Univ Ireland, Galway, Ireland
[2] Nottingham Trent Univ, Nottingham, England
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2547
引用
收藏
页数:1
相关论文
共 50 条
  • [1] miR-342 modulates 104 expression in breast cancer
    Crippa, Elisabetta
    Lusa, Lara
    Fiorino, Antonio
    Marchesi, Edoardo
    De Cecco, Loris
    Pierotti, Marco A.
    Gariboldi, Manuela
    CANCER RESEARCH, 2012, 72
  • [2] Expression Analysis of MiR-21, MiR-205, and MiR-342 in Breast Cancer in Iran
    Savad, Shahram
    Mehdipour, Parvin
    Miryounesi, Mohammad
    Shirkoohi, Reza
    Fereidooni, Forouzandeh
    Mansouri, Fatemeh
    Modarressi, Mohammad Hossein
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (03) : 873 - 877
  • [3] miR-342 is associated with estrogen receptor-α expression and response to tamoxifen in breast cancer
    He, Yue-Jun
    Wu, Jian-Zhong
    Ji, Ming-Hua
    Ma, Tao
    Qiao, En-Qi
    Ma, Rong
    Tang, Jin-Hai
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 5 (03) : 813 - 818
  • [4] Downregulation of miR-342 is associated with tamoxifen resistant breast tumors
    Cittelly, Diana M.
    Das, Partha M.
    Spoelstra, Nicole S.
    Edgerton, Susan M.
    Richer, Jennifer K.
    Thor, Ann D.
    Jones, Frank E.
    MOLECULAR CANCER, 2010, 9
  • [5] Downregulation of miR-342 is associated with tamoxifen resistant breast tumors
    Diana M Cittelly
    Partha M Das
    Nicole S Spoelstra
    Susan M Edgerton
    Jennifer K Richer
    Ann D Thor
    Frank E Jones
    Molecular Cancer, 9
  • [6] miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer
    Crippa, Elisabetta
    Lusa, Lara
    De Cecco, Loris
    Marchesi, Edoardo
    Calin, George Adrian
    Radice, Paolo
    Manoukian, Siranoush
    Peissel, Bernard
    Daidone, Maria Grazia
    Gariboldi, Manuela
    Pierotti, Marco Alessandro
    PLOS ONE, 2014, 9 (01):
  • [7] Survival relevance of tamoxifen sensitivity-related microRNAs, miR-342 and miR-221/222, in breast cancer patients
    Young, Jessica S.
    Kawaguchi, Tsutomu
    Yan, Li
    Qi, Qianya
    Liu, Song
    Takabe, Kazuaki
    CANCER RESEARCH, 2018, 78 (04)
  • [8] Epigenetic silencing of EVL/miR-342 in multiple myeloma
    Li, Zhenhai
    Wong, Kwan Yeung
    Chan, Godfrey Chi-Fung
    Chng, Wee-Joo
    Chim, Chor Sang
    TRANSLATIONAL RESEARCH, 2018, 192 : 46 - 53
  • [9] MiR-342 regulates cell proliferation and apoptosis in hepatocellular carcinoma through Wnt/β-catenin signaling pathway
    Lu, Chang
    Jia, Shengnan
    Zhao, Shutao
    Shao, Xue
    CANCER BIOMARKERS, 2019, 25 (01) : 115 - 126
  • [10] miR-342 overexpression results in a synthetic lethal phenotype in BRCA1-mutant HCC1937 breast cancer cells
    Crippa, Elisabetta
    Folini, Marco
    Pennati, Marzia
    Zaffaroni, Nadia
    Pierotti, Marco A.
    Gariboldi, Manuela
    ONCOTARGET, 2016, 7 (14) : 18594 - 18604